Argotec Restructures TPU Film Business to Better Serve Medical Device Industry

July 24, 2009

2 Min Read
Argotec Restructures TPU Film Business to Better Serve Medical Device Industry



 TPU films offer softness and breathability characteristics that make them suited for use in wound-care applications.

To better serve the medical device and wound-care product manufacturing industries, Argotec Inc. (Greenfield, MA) has restructured its thermoplastic polyurethane (TPU) film business. The company is taking a more application-oriented approach to the way it bundles groups of like products and resources."Instead of focusing just on products we can make and market, we are concentrating on better matching our film extrusion capabilities, technical expertise, and resources with the applications of our customers," says Bruce Wilby, Argotec president and CEO. Recognizing a trend among medical product manufacturers of increasingly using polyurethane films in conversion, fabrication, and pressure-sensitive adhesive coating processes, the company is highlighting the performance characteristics of its Argomed TPU products that are suited for those applications.Converters, fabricators, and manufacturers are specifying TPU film for medical device and wound-care products because of its high rate of moisture-vapor transpiration breathability, softness, and stretchability, according to the company. Available with antimicrobial infection control technology, the company says its TPU film and sheet products contain no plasticizers that can cause allergic reactions in patients or make a product more brittle, which can reduce its potential shelf life. Compatible with most commercial adhesive systems, the TPU films also can withstand multiple commerical cleanings as well as EtO, gamma, and autoclave sterilization. The company can extrude TPU in film and sheet thicknesses ranging from 0.2 to 125 mm and widths up to 86 in.The restructuring is also a response to customer requests for a film supplier that can act as a partner in solving specific application challenges. "We feel that the investments we have made in equipment, facilities, along with restructuring our business in a way that allows us to more effectively focus those resources on solving customers' design and production challenges, is a clear answer to that call," Wilby says.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like